Osmolyte Trimethylamine N-Oxide Converts Recombinant α-Helical Prion Protein to its Soluble β-Structured Form at High Temperature

Journal of Molecular Biology

Volumn 362, Issue 4, 2006, Pages 810-820

  Nandi, P K ^a   Bera, A ^a   Sizaret, P Y ^b  

^a UR1282   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

amyloid; osmolyte; prion; prion protein; soluble prion protein oligomers

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; ACRYLAMIDE; OLIGOMER; PRION PROTEIN; PROTEINASE K; RECOMBINANT PROTEIN; THIOFLAVINE; TRIMETHYLAMINE OXIDE; TRYPTOPHAN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; FLUORESCENCE; HIGH TEMPERATURE PROCEDURES; HUMAN; HUMAN CELL; OSMOSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN INDUCTION; PROTEIN STRUCTURE; THERMOREGULATION;

EID: 33748327055     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.07.060     Document Type: Article

References (58)

1. Prusiner S.B. Prions. Proc. Natl Acad. Sci USA 95 (1998) 13363-13833
2. Brown D.R., Schmidt B., and Kretzschmar H.A. Effects of copper on survival of prion protein knockout neurons and glia. J. Neurochem. 70 (1998) 1686-1693
3. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., et al. Signal transduction through prion protein. Science 289 (2000) 1925-1928
4. Derrington E., Gabus C., Leblanc C., Chnaidermann J., Grave L., Dormont D., et al. PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. C. R. Biol. 325 (2002) 17-23
5. Chesebro B. BSE and prions: uncertainties about the agent. Science 279 (1998) 42-43
6. Manuelidis L., Sklaviadis T., Akoitz A., and Fritch W. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc. Natl Acad. Sci. USA 23 (1995) 5124-5128
7. Legname G., Baskakov I.V., Nguyen H.-O.B., Riesner D., Cohen F.E., DeArmond S.J., et al. Synthetic mammalian prions. Science 305 (2004) 673-676
8. Legname G., Nguyen H.-O.B., Baskakov I.V., Cohen F.E., and Prusiner S.B. Strain-specified characteristics of mouse synthetic prions. Proc. Natl Acad. Sci. USA 102 (2005) 2168-2173
9. Castilla J., Saá P., Hetz C., and Soto C. In vitro generation of infectious scrapie prions. Cell 121 (2005) 195-206
10. Silveria J.R., Raymond G.J., Hughson A.G., Race R.E., Sim V.L., Hayes S.F., et al. The most infectious prion protein particles. Nature 437 (2005) 257-261
11. Leffers K.-W., Willie H., Stohr J., Junger E., and Riesner D. Assembly of natural and recombinant prion protein into fibrils. Biol. Chem. 386 (2005) 569-580
12. Deleault N.R., Geoghegan J.C., Nishina K., Kascsak R., Williamson R.A., and Supattapone S. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J. Biol. Chem. 280 (2005) 26873-26879
13. Cordeiro Y., Machado F., Juliano L., Juliano M.A., Brentani R.R., and Foguel D. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation. J. Biol. Chem. 276 (2001) 49400-49409
14. Nandi P.K., and Leclerc E. Polymerization of murine recombinant prion protein in nucleic acid solution. Arch. Virol. 144 (1999) 1751-1763
15. Adler V., Zeiler B., Kryukov V., Kascsak R., Rubenstein R., and Grossman A. Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J. Mol. Biol. 332 (2003) 47-57
16. Deleault N.R., Lucassen R.W., and Supattapone S. RNA molecules stimulate prion protein conversion. Nature 425 (2003) 717-720
17. Cordeiro Y., Lima L.M., Gomes M.P., Foguel D., and Silva J.L. Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4′-dianilino-1,1′-binaphthyl-5,5′-sulfonate (bis-ANS). J. Biol. Chem. 279 (2004) 5346-5352
18. Giese A., Levin J., Bertsch U., and Kretzschmar H. Effect of metal ions on de novo aggregation of full-length prion protein. Biochem. Biophys. Res. Commun. 320 (2004) 1240-1246
19. Leffers K.W., Schell J., Jansen K., Lucassen R., Kaimann T., Haertle T., et al. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites. J. Mol. Biol. 344 (2004) 839-853
20. Bocharova O.V., Breydo L., Parfenov A.S., Salnikov V.V., and Baskakov I.V. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J. Mol. Biol. 346 (2005) 645-659
21. Rezaei H., Eghiaian F., Perez J., Doublet B., Choiset Y., Nagel-Steger L., et al. Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities. J. Mol. Biol. 347 (2005) 665-679
22. Luhrs T., Zahn R., and Wuthrich K. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions. J. Mol. Biol. 357 (2006) 833-841
23. Frankenfield K.N., Powers E.T., and Kelly J.W. Influence of the N-terminal domain on the aggregation properties of the prion protein. Protein Sci. 14 (2005) 2154-2166
24. Nandi P.K., Leclerc E., and Marc D. Unusual property of prion protein unfolding in neutral salt solution. Biochemistry 41 (2002) 11017-11024
25. Qu Y., Bolen C.L., and Bolen D.W. Osmolyte-driven contraction of a random coil protein. Proc. Natl. Acad. Sci. USA 95 (1998) 9268-9273
26. Bolen D.W., and Baskakov I.V. The osmophobic effect: natural selection of a thermodynamic force in protein folding. J. Mol. Biol. 310 (2001) 955-960
27. Scheibel T., and Lindquist S.L. The role of conformational flexibility in prion propagation and maintenance for Sup35p. Nature Struct. Biol. 8 (2001) 958-965
28. Gursky O. Probing the conformation of a human apolipoprotein C-1 by amino acid substitutions and trimethylamine-N-oxide. Protein Sci. 8 (1999) 2055-2064
29. Celinski S.A., and Scholtz J.M. Osmolyte effects on helix formation in peptides and the stability of coiled-coils. Protein Sci. 11 (2002) 2048-2051
30. Tatzelt J., Prusiner S.B., and Welch W.J. hemical chaperones interfere with the formation of scrapie prion protein. EMBO J. 15 (1996) 6363-6373
31. Speare J.O., Rush III T.S., Bloom M.E., and Caughey B. The role of helix 1 aspartates and salt bridges in the stability and conversion of prion protein. J. Biol. Chem. 278 (2003) 12522-12529
32. Janek K., Behlke J., Zipper Z., Fabian H., Georgalis Y., Beyermann M., et al. Water-soluble beta-sheet models which self-assemble into fibrilar structures. Biochemistry 38 (1999) 8246-8252
33. Niraula T.N., Konno T., Li H., Yamada H., Akasaka K., and Tatchibana H. Pressure-dissociable reversible assembly of intrinsically denatured lysozyme is a precursor for amyloid fibrils. Proc. Natl Acad. Sci. USA 101 (2004) 4089-4093
34. Jeffrey M., Goodsir C.M., Holliman A., Higgins R.J., Bruce M.E., McBride P.A., et al. Determination of the frequency and distribution of vascular and parenchymal amyloid with polyclonal and N-terminal-specific PrP antibodies in scrapie-affected sheep and mice. Vet. Rec. 16 (1998) 534-537
35. Hope J., Morton L.J., Farquhar C.F., Multhaup J., and Kimberlin R.H. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J. 5 (1986) 2591-2597
36. Stöckel J., and Hartl U. Chaperonin-mediated de novo generation of prion protein aggregates. J. Mol. Biol. 313 (2005) 861-872
37. Morillas M., Swietnicki W., Gambetti P., Surewicz W.K., and Haertle T. Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274 (1999) 36859-36865
38. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24 (1999) 329-332
39. Prusiner S.B., Scott M.R., DeArmond S.J., and Cohen F.E. Prion protein biology. Cell 93 (1998) 337-348
40. Morillas M., Vanik D.L., and Surewicz W.K. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein. Biochemistry 40 (2001) 6982-6987
41. Nandi P.K., Lelerc E., Nicole J.-C., and Takahashi M. DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. J. Mol. Biol. 322 (2002) 153-161
42. Safar J., Roller P.P., Gajdusek D.C., and Gibbs Jr. C.J. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268 (1993) 20276-20284
43. Bennion B.J., DeMarco M.L., and Daggett V. Preventing misfolding of the prion protein by trimethylamine N-oxide. Biochemistry 43 (2004) 12955-12963
44. Singh R.K., Haque I., and Ahmad F. Counteracting osmolyte trimethylamine N-oxide destabilizes proteins at pH below its pKa. Measurements of thermodynamic parameters of proteins in the presence and absence of trimethylamine N-oxide. J. Biol. Chem. 280 (2005) 11035-11042
45. Brown C.R., Hong-Brown L.Q., and Welch W.J. Correcting temperature-sensitive protein folding defects. J. Clin. Invest. 99 (1997) 1432-1444
46. Song J.-L., and Chuang D.T. Natural Osmolyte Trimethylamine N-oxide corrects assembly defects of mutant branched-chain α-ketoacid decarboxylase in maple syrup urine disease. J. Biol. Chem. 276 (2001) 40241-40246
47. Devlin G.L., Parfrey H., Tew D.J., Lomas D.A., and Bottomley S.P. Prevention of Ppolymerization of M and Z-antitrypsin (a-AT) with trimethylamine N-oxide. Implications for the treatment of-AT deficiency. Am. J. Respir. Cell Mol. Biol. 24 (2001) 727-732
48. Yang D.-S., Yip C.M., Huang J., Chakarabartty A., and Fraser P.E. Manipulating the amyloid-beta aggregation pathway with chemical chaperones. J. Biol. Chem. 274 (1999) 32970-32974
49. Uversky V.N., Li J., and Fink A.L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 276 (2001) 10737-10744
50. Uversky V.N., Li J., and Fink A.L. Trimethylamine-N-oxide-induced folding of alpha-synuclein. FEBS Letters 509 (2001) 31-35
51. Auton M., and Bolen D.W. Additive transfer free energies of the peptide backbone unit that are independent of model compounds and the choice of concentration scale. Biochemistry 43 (2004) 1329-1342
52. Athawale M.V., Dordick J.S., and Garde S. Osmolyte trimethylamine-N-oxide does not affect the strength of hydrophobic interactions: origin of osmolyte compatibility. Biophys. J. 89 (2005) 858-866
53. Fandrich M., and Dobson C.M. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 21 (2002) 5682-5690
54. Abkevich V.I., Gutin A.M., and Shakhnovich E.I. Theory of kinetic partitioning in protein folding with possible applications to prions. Proteins: Struct. Funct. Genet. 31 (1998) 335-344
55. Cohen F.E. Protein misfolding and prion diseases. J. Mol. Biol. 293 (1999) 313-320
56. Caughey B., and Lansbury P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26 (2003) 267-298
57. Rezaei H., Marc D., Choiset Y., Takahashi M., Hoa G.H.B., Haertle T., et al. High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility. Eur. J. Biochem. 267 (2000) 2833-2839
58. Liemann S., and Glockshuber R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38 (1999) 3258-3267